economy
Pharma stocks are showing strength. Charts predict this name could break out next
Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within healthcare.
TL;DR
- Pharmaceutical stocks are outperforming the broader market and showing sector leadership.
- Eli Lilly is a bellwether, already at all-time highs, boosting the iShares U.S. Pharmaceuticals ETF (IHE).
- IHE is extending its uptrend, confirmed by a MACD crossover, indicating renewed intermediate-term momentum.
- Johnson & Johnson (JNJ) shows constructive technical signals, including an oversold upturn and improving momentum.
- Key levels for JNJ are support at the 200-day MA (~$213) and resistance near $249.
- JNJ has an active countertrend 'buy' signal from DeMARK Indicators and a daily MACD 'buy' signal.
- The JNJ vs. SPX Index ratio is in a cyclical upmove, approaching support at its 40-week MA, suggesting potential for further outperformance.
- Pharma leadership is reinforced by IHE's new highs, and JNJ's signals suggest potential rotation into other large-cap bellwethers.